![Brian Atwood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Atwood
Direktor/Vorstandsmitglied bei
Biotechnology Innovation Organization
Vermögen: 246 $ am 31.07.2026
Profil
Brian G.
Atwood founded Glycomed, Inc. in 1987, where he worked as President & Chief Executive Officer in 1995, Versant Ventures I LLC in 1999, where he worked as Managing Director, Versant Venture Management LLC in 1999, where he worked as Managing Director, and various other companies.
Mr. Atwood also founded PE Corp.
(New York), where he worked as Director and Perkin-Elmer Cetus Instruments, where he worked as Director.
Mr. Atwood also currently works at Biotechnology Innovation Organization, as Director, Launch One Acquisition Corp., as Independent Director from 2024, and CERo Therapeutics Holdings, Inc., as Director from 2024.
Mr. Atwood also formerly worked at Five Prime Therapeutics, Inc., as Chairman from 2002 to 2016, Veracyte, Inc., as Chairman from 2008 to 2016, Atreca, Inc., as Chairman from 2013 to 2024, and various other companies.
Mr. Atwood received his graduate degree from the University of California, Davis, undergraduate degree from the University of California, Irvine, and Masters Business Admin degree from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,03 % | 28.04.2026 | 24 591 ( 0,03 % ) | 246 $ | 31.07.2026 |
Aktive Positionen von Brian Atwood
| Unternehmen | Position | Beginn |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brian Atwood
| Unternehmen | Position | Ende |
|---|---|---|
| ATRECA, INC. | Vorsitzender | 01.04.2024 |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Vorsitzender | 01.02.2024 |
| CLOVIS ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 10.07.2023 |
| EFFECTOR THERAPEUTICS, INC. | Vorsitzender | 01.08.2021 |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Gründer | 01.02.2018 |
Ausbildung von Brian Atwood
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
38
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 38 |
|---|---|
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals based on complex carbohydrates | Health Technology |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Provides real time in-vivo imaging services | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Versant Ventures I LLC | |
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services Involved in the study of biological systems | Commercial Services |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Versant Venture Capital III LP
 Versant Venture Capital III LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Versant Ventures II LLC | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Groove Biopharma Corp.
 Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the generation of novel microRNA therapeutics | Commercial Services |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Brentwood Venture Capital
 Brentwood Venture Capital Investment ManagersFinance Brentwood Venture Capital invests in middle market companies in the US. The firm targets companies operating in the fields of information technology and health care. It provides financing for early stage capital requirements. | Finance |
PE Corp. (New York)
 PE Corp. (New York) Medical SpecialtiesHealth Technology Provides computer software and solutions | Health Technology |
Brentwood Associates
 Brentwood Associates Investment ManagersFinance Brentwood Associates invests in middle market growth companies located in the United States with an EBITDA of up to USD 50 million and revenues of USD 20 - 500 million. The firm focuses on a broad range of sectors and industries. It participates in MBOs, recapitalizations and growth stage capital transactions with an investment size of USD 20 - 200 million. The firm acquires majority and minority interest and it takes a seat on the board of directors. | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Helicos Biosciences Corp.
 Helicos Biosciences Corp. Miscellaneous Commercial ServicesCommercial Services Provides solutions for solving problems in biology and medicine | Commercial Services |
Saegis Pharmaceuticals, Inc.
 Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ForteBio, Inc.
 ForteBio, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets biomolecular analysis products | Health Technology |
Versant Ventures III LLC | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
PhaseRx, Inc.
 PhaseRx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures enzyme replacement therapies | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Versant Ventures IV LLC | |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Spark Diagnostics, Inc.
 Spark Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perkin-Elmer Cetus Instruments | |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Cadence Pharmaceuticals , Inc. | Health Technology |
